1 材料与方法
1.1 试验设计和饲粮
表1 颗粒料组成及营养水平(干物质基础)Table 1 Composition and nutrient levels of pellet diets (DM basis) % |
| 项目 Items | 高蛋白质组 High protein group | 中蛋白质组 Medium protein group | 低蛋白质组 Low protein group |
|---|---|---|---|
| 原料Ingredients | |||
| 玉米Corn | 55.0 | 57.5 | 59.0 |
| 棉籽粕Cottonseed meal | 29.0 | 15.2 | 8.0 |
| 豆粕Soybean meal | 10.0 | 19.0 | 22.5 |
| 麸皮Bran | 1.0 | 3.0 | 5.0 |
| 大豆油Soybean oil | 0.3 | 0.5 | |
| 预混料Premix1) | 5.0 | 5.0 | 5.0 |
| 合计Total | 100.0 | 100.0 | 100.0 |
| 营养水平Nutrient levels2) | |||
| 综合净能NEmf/(MJ/kg) | 5.40 | 5.62 | 5.70 |
| 粗蛋白质CP | 22.05 | 20.01 | 18.56 |
| 粗脂肪EE | 5.11 | 4.95 | 4.02 |
| 中性洗涤纤维NDF | 25.87 | 24.46 | 25.93 |
| 酸性洗涤纤维ADF | 15.34 | 14.08 | 14.99 |
| 粗灰分Ash | 7.13 | 7.01 | 6.98 |
| 钙Ca | 0.6 | 0.8 | 1.0 |
| 磷P | 0.4 | 0.5 | 0.5 |
1)预混料为每千克颗粒料提供 The premix provided the following per kg of pellet diets:VA 250 000 IU,VD 60 000 IU,VE 1 000 IU,Fe 80 mg,Cu 12 mg,Zn 80 mg,Mn 70 mg,Se 0.40 mg,I 1 mg,Co 0.80 mg。 | |
2)综合净能参考NASEM(2016)计算,其余为实测值。NEmf was calculated by reference to NASEM (2016), while the others were measured values. |
表2 苜蓿干草营养成分Table 2 Nutrients in alfalfa hay |
| 项目Items | 含量Content |
|---|---|
| 干物质DM/% | 92.96 |
| 粗蛋白质CP/% DM | 8.63 |
| 粗脂肪EE/% DM | 2.57 |
| 粗灰分Ash/% DM | 5.52 |
| 中性洗涤纤维NDF/% DM | 54.53 |
| 酸性洗涤纤维ADF/% DM | 26.11 |
| 钙Ca/% DM | 0.59 |
| 磷P/% DM | 0.30 |
| 总能GE/(MJ/kg DM) | 20.08 |
1.2 样品采集
1.2.1 饲粮样品的采集
1.2.2 血清样品的采集
1.3 测定指标及方法
1.3.1 饲粮营养成分含量测定
1.3.2 犊牛生长性能指标
1.3.3 血清生化、免疫和抗氧化指标测定
1.3.4 血清代谢物检测
1.4 数据统计分析
2 结果与分析
2.1 饲粮蛋白质水平对犊牛生长性能的影响
表3 饲粮蛋白质水平对犊牛生长性能的影响Table 3 Effects of dietary protein level on growth performance of calves |
| 项目 Items | 高蛋白质组 High protein group | 中蛋白质组 Medium protein group | 低蛋白质组 Low protein group | P值 P-value |
|---|---|---|---|---|
| 初生重Birth body weight/kg | 45.28±2.04 | 43.14±2.16 | 42.89±2.43 | 0.156 |
| 第30天体重Body weight on day 30/kg | 98.43±13.04 | 90.95±14.64 | 92.63±15.83 | 0.234 |
| 第60天体重Body weight on day 60/kg | 169.54±24.50a | 143.35±24.82b | 128.51±16.19b | <0.001 |
| 第90天体重Body weight on day 90/kg | 185.60±11.01a | 165.39±13.21b | 158.75±12.56b | <0.001 |
| 平均日增重ADG/(kg/d) | 1.65±0.23a | 1.24±0.11b | 1.17±0.08b | 0.025 |
| 干物质采食量DMI/(kg/d) | 1.28±0.28 | 1.25±0.19 | 1.03±0.25 | 0.178 |
| 颗粒料采食量Pellet diet intake/(kg/d) | 1.12±0.15 | 0.98±0.06 | 0.92±0.21 | 0.370 |
| 苜蓿干草采食量Alfalfa hay intake/(kg/d) | 0.74±0.03 | 0.68±0.02 | 0.71±0.02 | 0.172 |
| 料重比F/G | 1.29±0.48 | 1.55±0.51 | 1.14±0.04 | 0.452 |
2.2 饲粮蛋白质水平对犊牛血清生化、免疫和抗氧化指标的影响
表4 饲粮蛋白质水平对犊牛血清生化、免疫和抗氧化指标的影响Table 4 Effects of dietary protein level on serum biochemical, immune and antioxidant indices of calves |
| 项目 Items | 高蛋白质组 High protein group | 中蛋白质组 Medium protein group | 低蛋白质组 Low protein group | P值 P-value |
|---|---|---|---|---|
| 总蛋白TP/(g/L) | 75.37±1.20a | 69.17±5.11b | 62.42±2.46b | 0.036 |
| 甘油三酯TG/(mmol/L) | 0.39±0.14 | 0.39±0.12 | 0.25±0.07 | 0.332 |
| 葡萄糖GLU/(mmol/L) | 7.01±0.30a | 5.85±0.40b | 3.10±0.18b | <0.001 |
| 免疫球蛋白A IgA/(mg/mL) | 7.39±0.20a | 5.35±0.33b | 3.62±0.21b | <0.001 |
| 免疫球蛋白G IgG/(mg/mL) | 13.12±1.00 | 12.47±0.45 | 10.24±1.36 | 0.443 |
| 免疫球蛋白M IgM/(mg/mL) | 4.86±0.21 | 4.06±0.57 | 4.12±0.55 | 0.203 |
| 白细胞介素-4 IL-4/(pg/mL) | 92.24±5.92a | 90.93±4.18ab | 84.64±3.61b | 0.046 |
| 肿瘤坏死因子-α TNF-α/(pg/mL) | 234.88±13.87b | 252.49±14.46a | 259.09±19.24a | 0.029 |
| 超氧化物歧化酶SOD/(U/mL) | 64.69±10.69a | 60.62±1.81b | 48.89±0.18b | <0.001 |
| 谷胱甘肽过氧化物酶GSH-Px/(U/mL) | 5.57±1.24a | 3.00±1.72b | 2.77±0.41b | 0.023 |
| 丙二醛MDA/(nmol/mL) | 4.39±0.05b | 5.34±0.12a | 6.03±0.04a | 0.029 |
| 总抗氧化能力T-AOC/(μmol/mL) | 1.23±0.15a | 1.00±0.05b | 0.23±0.01b | <0.001 |
2.3 饲粮蛋白质水平对犊牛血清代谢物的影响
2.3.1 多元变量模式识别分析
2.3.2 血清差异代谢物的筛选
图3 饲粮蛋白质水平对犊牛血清代谢物的影响A、C和E为差异代谢物火山图,B、D和F为前20种差异代谢物。A和B表示低蛋白质组与中蛋白质组相比,C和D表示低蛋白质组与高蛋白组相比,E和F表示高蛋白质组与中蛋白质组相比。 Fig.3 Effects of dietary protein level on serum metabolites of calves A, C and E were volcano plots of differential metabolites, and B, D and F were top 20 differential metabolites. A and B represented low protein group vs. medium protein group, C and D represented low protein group vs. high protein group, and E and F represented high protein group vs. medium protein group. |
表5 饲粮蛋白质水平对犊牛血清代谢物的影响Table 5 Effects of dietary protein level on serum metabolites of calves |
| 项目 Items | 代谢物 Metabolites | 含量变化 Content change | 变量投影 重要性 VIP | log2 (差异倍数) log2 (fold change) | |||||
|---|---|---|---|---|---|---|---|---|---|
| 低蛋白质组与中蛋白质组相比Low protein group vs. medium protein group | |||||||||
| 1 | 3,3,14,14-四甲基十六烷二酸 3,3,14,14-tetramethyl-hexadecanedioic acid | 下调 | 1.82 | -2.05 | |||||
| 2 | (+)-γ-生育酚(+)-gamma-tocopherol | 下调 | 1.79 | -1.86 | |||||
| 3 | N-丙二酰基-γ-氨基丁酸 N-arachidonoyl-gamma-aminobutyric acid | 下调 | 1.75 | -1.43 | |||||
| 4 | 前列腺素B2 Prostaglandin B2 | 下调 | 1.88 | -1.41 | |||||
| 5 | 钙化醇Calciferol | 下调 | 1.84 | -1.40 | |||||
| 6 | 羊毛甾醇Lanosterol | 下调 | 1.66 | -1.36 | |||||
| 7 | L-哌啶酸L-pipecolic acid | 下调 | 1.88 | -1.34 | |||||
| 8 | 十七烷基-4-烯烃Heptadecasphing-4-enine | 下调 | 1.70 | -1.27 | |||||
| 9 | 泛酸Pantothenate | 下调 | 1.72 | -1.24 | |||||
| 10 | 反式-4-(氨基甲基)环己烷羧酸 Trans-4-(aminomethyl)cyclohexanecarboxylic acid | 下调 | 1.87 | -1.16 | |||||
| 11 | N-果糖酰异亮氨酸N-fructosyl isoleucine | 下调 | 2.01 | -1.01 | |||||
| 12 | 三甲胺N-氧化物Trimethylamine N-oxide | 下调 | 1.83 | -0.78 | |||||
| 13 | 獐牙马素Swertiamarin | 下调 | 1.78 | -0.66 | |||||
| 14 | 季戊四醇四(3,5-二叔丁基-4-羟基氢化肉桂酸酯) Pentaerythritol tetrakis(3,5-di-tert-butyl-4-hydroxyhydrocinnamate) | 下调 | 1.71 | -0.62 | |||||
| 15 | L-苏氨酸L-threonine | 下调 | 2.07 | -0.60 | |||||
| 16 | 4'-O-beta-D-葡萄糖基-5-O-甲基维沙米醇 4'-O-beta-D-glucosyl-5-O-methylvisamminol | 上调 | 1.75 | 0.70 | |||||
| 17 | 1-苯甲酰-2-羟基-sn-甘油-3-磷酸胆碱 1-behenoyl-2-hydroxy-sn-glycero-3-phosphocholine | 上调 | 2.00 | 0.73 | |||||
| 18 | (r)-丁酰肉碱(r)-butyrylcarnitine | 上调 | 1.76 | 0.74 | |||||
| 19 | 肉碱Carnitine | 上调 | 1.90 | 0.75 | |||||
| 20 | 美托洛尔酸Metoprolol acid | 上调 | 1.78 | 0.95 | |||||
| 21 | 异戊酰-L-肉碱Isovaleryl-L-carnitine | 上调 | 1.87 | 1.14 | |||||
| 22 | 11-脱氧前列腺素E1 11-deoxyprostaglandin E1 | 上调 | 1.81 | 1.32 | |||||
| 23 | 钙霉素Calcimycin | 上调 | 1.88 | 1.33 | |||||
| 24 | 前列腺素F2α 1,9-内酯Prostaglandin F2alpha 1,9-lactone | 上调 | 1.79 | 1.41 | |||||
| 25 | 环吡酮β-D-葡糖苷酸Ciclopirox beta-D-glucuronide | 上调 | 1.81 | 1.44 | |||||
| 26 | 15-环己基戊醇前列腺素F2α 15-cyclohexylpentanorprostaglandin F2alpha | 上调 | 1.86 | 1.51 | |||||
| 27 | 前列腺素F3a PGF3a | 上调 | 2.01 | 1.78 | |||||
| 28 | δ17-6-酮前列腺素F1α Delta17-6-ketoprostaglandin F1alpha | 上调 | 1.85 | 2.15 | |||||
| 29 | 甘氨鹅脱氧胆酸Glycochenodeoxycholic acid | 上调 | 2.01 | 2.29 | |||||
| 低蛋白质组与高蛋白质组相比Low protein group vs. high protein group | |||||||||
| 1 | 鹅去氧胆酸24-酰基-β-D-葡糖苷酸 Chenodeoxycholic acid 24-acyl-beta-D-glucuronide | 下调 | 1.74 | -4.80 | |||||
| 2 | 熊果胆酸Ursocholic acid | 下调 | 1.85 | -3.22 | |||||
| 3 | 脱氧胆酸Deoxycholic acid | 下调 | 1.80 | -2.91 | |||||
| 4 | (r)-4-((3r,5s,7r,8r,9s,10s,12r,13r,14s,17r)-3,7,12-三羟基- 10,13-二甲基十六氢-1氢-环戊并[a]菲-17-基)戊酸 (r)-4-((3r,5s,7r,8r,9s,10s,12r,13r,14s,17r)-3,7,12-trihydroxy-10,13- dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid | 下调 | 1.71 | -2.72 | |||||
| 5 | 3,3,14,14-四甲基十六烷二酸 3,3,14,14-tetramethyl-hexadecanedioic acid | 下调 | 1.84 | -2.51 | |||||
| 6 | 胆酸Cholic acid | 下调 | 1.86 | -2.47 | |||||
| 7 | 雄甾酮葡糖苷酸Androsterone glucuronide | 下调 | 1.83 | -2.40 | |||||
| 8 | 前列腺素B2 Prostaglandin B2 | 下调 | 1.88 | -2.31 | |||||
| 9 | 3-羟基司坦唑醇葡糖苷酸3-hydroxystanozolol glucuronide | 下调 | 1.88 | -2.24 | |||||
| 10 | 异羟基乙酸Isoevernic acid | 下调 | 1.72 | -2.23 | |||||
| 11 | 普伐他汀Pravastatin | 下调 | 1.92 | -2.20 | |||||
| 12 | 羊毛甾醇Lanosterol | 下调 | 1.70 | -2.19 | |||||
| 13 | 磷脂酰肌醇34∶0 Pi 34∶0 | 下调 | 1.68 | -2.04 | |||||
| 14 | 3-羟基异戊酸3-hydroxyisovaleric acid | 下调 | 1.65 | -1.99 | |||||
| 15 | 2-羟基腺嘌呤2-hydroxyadenine | 下调 | 1.65 | -1.94 | |||||
| 16 | 羟基脂肪酸支链脂肪酸酯28∶0 FAHFA 28∶0 | 下调 | 1.90 | -1.88 | |||||
| 17 | (+)-γ-生育酚(+)-gamma-tocopherol | 下调 | 1.73 | -1.84 | |||||
| 18 | 醋酸,2-[[(2z)-4-[(1r,2r,3r,5r)-5-氯-2-[(3r)-3-环己基-3- 羟丙基]-3-羟基环戊基]-2-丁烯-1-基]氧基]-1-甲基乙基酯 Acetic acid,2-[[(2z)-4-[(1r,2r,3r,5r)-5-chloro-2-[(3r)-3-cyclohexyl-3- hydroxypropyl]-3-hydroxycyclopentyl]-2-buten-1-yl]oxy]-1-methylethyl ester | 下调 | 1.87 | -1.80 | |||||
| 19 | 1-甲基鸟苷1-methylguanosine | 下调 | 1.77 | -1.67 | |||||
| 20 | 7-甲基鸟苷7-methylguanosine | 下调 | 1.79 | -1.55 | |||||
| 21 | 石胆酸Lithocholic acid | 下调 | 1.73 | -1.47 | |||||
| 22 | 3-甲氧基利马前列腺素3-methoxy limaprost | 下调 | 1.59 | -1.43 | |||||
| 23 | 十七烷基-4-烯烃Heptadecasphing-4-enine | 下调 | 1.88 | -1.30 | |||||
| 24 | 1-单亚麻酸甘油酯1-monolinoleoyl-rac-glycerol | 下调 | 1.64 | -1.24 | |||||
| 25 | N-果糖酰异亮氨酸N-fructosyl isoleucine | 下调 | 1.65 | -1.18 | |||||
| 26 | N,n-二甲基鸟苷N,n-dimethylguanosine | 下调 | 1.83 | -1.17 | |||||
| 27 | 熊胆酸 3alpha,7beta,12alpha-trihydroxy-5beta-cholan-24-oic acid | 下调 | 1.74 | -1.13 | |||||
| 28 | 精氨基缬氨酸Arg-Val | 下调 | 1.73 | -1.09 | |||||
| 29 | 吲哚Indole | 下调 | 1.64 | -1.08 | |||||
| 30 | 三甲胺N-氧化物Trimethylamine N-oxide | 下调 | 1.86 | -1.04 | |||||
| 31 | D-喹喹糖D-quinovose | 下调 | 1.69 | -0.99 | |||||
| 32 | 苯乙酸Phenyllactic acid | 下调 | 1.83 | -0.96 | |||||
| 33 | L-苏氨酸L-threonine | 下调 | 1.79 | -0.96 | |||||
| 34 | 棉酚Gossypol | 下调 | 1.61 | -0.83 | |||||
| 35 | 缬氨酰丙氨酰赖氨酸Val-Ala-Lys | 下调 | 1.83 | -0.83 | |||||
| 36 | L-正亮氨酸L-norleucine | 下调 | 1.65 | -0.77 | |||||
| 37 | 季戊四醇四(3-(3,5-二叔丁基-4-羟基苯基)丙酸酯) Pentaerythritol tetrakis(3,5-di-tert-butyl-4-hydroxyhydrocinnamate) | 下调 | 1.81 | -0.72 | |||||
| 38 | 暹罗皂苷i Siamenoside i | 上调 | 1.67 | 0.62 | |||||
| 39 | 异戊酰-L-肉碱Isovaleryl-L-carnitine | 上调 | 1.55 | 0.64 | |||||
| 40 | 假白藜芦碱Pseudojervine | 上调 | 1.83 | 0.74 | |||||
| 41 | N-去-(4,4-二氟环己甲酰氧基)-N-苄氧羰基-3- 叔丁基二甲基硅氧基甲基马拉韦罗 N-des-(4,4-difluorocyclohexanecarboxy)-N- carbobenzyloxy-3-tert-butyldimethylsilyloxymethylmaraviroc | 上调 | 1.67 | 0.75 | |||||
| 42 | 茄边碱Solamargine | 上调 | 1.69 | 0.78 | |||||
| 43 | 1-山嵛酰基-2-羟基-sn-甘油-3-磷酸胆碱 1-behenoyl-2-hydroxy-sn-glycero-3-phosphocholine | 上调 | 1.71 | 0.79 | |||||
| 44 | 1-二十糖酰基-sn-甘油-3-磷酸胆碱 1-arachidoyl-2-hydroxy-sn-glycero-3-phosphocholine | 上调 | 1.65 | 0.83 | |||||
| 45 | N-[2-(二甲基氨基)乙基]-N-甲基-4-[[[[4-[4-(4-吗啉 基)-7-(2,2,2-三氟乙基)-7氢-吡咯并[2,3-D]嘧啶-2-基] 苯基]氨基甲酰基]氨基]-苯甲酰胺 N-[2-(dimethylamino)ethyl]-N-methyl-4-[[[[4-[4-(4-morpholinyl)- 7-(2,2,2-trifluoroethyl)-7H-pyrrolo[2,3-D]pyrimidin- 2-yl]phenyl]amino]carbonyl]amino]-benzamide | 上调 | 1.81 | 0.84 | |||||
| 46 | 利血平Reserpine | 上调 | 1.81 | 0.88 | |||||
| 47 | 1-棕榈酰基-2-(4-酮基十二烷-3-烯-二基)磷脂酰胆碱 1-palmitoyl-2-(4-ketododec-3-enedioyl)phosphatidylcholine | 上调 | 1.74 | 0.91 | |||||
| 48 | 升麻素苷H2 Cimicifugoside H2 | 上调 | 1.67 | 0.92 | |||||
| 49 | 丙硫菌唑Prothioconazole | 上调 | 1.67 | 0.94 | |||||
| 50 | 十氢甘柏酸Decahydrogambogic acid | 上调 | 1.65 | 0.96 | |||||
| 51 | 卡麦角林Cabergoline | 上调 | 1.64 | 0.99 | |||||
| 52 | 前列腺素F3a PGF3a | 上调 | 1.75 | 1.21 | |||||
| 53 | 3-(1氢-吲哚-3-基甲基)-6,18-二甲基-9-(2-甲基丙基)- 12-(1-异丙基)-15-丙-2-基-1,4,7,10,13,16,19-七氮 杂环二烷-2,5,8,11,14,17,20-庚酮 3-(1H-indol-3-ylmethyl)-6,18-dimethyl-9-(2-methylpropyl)- 12-(1-phenylethyl)-15-propan-2-yl-1,4,7,10,13,16,19- heptazacyclotricosane-2,5,8,11,14,17,20-heptone | 上调 | 1.65 | 1.27 | |||||
| 54 | 美托洛尔酸Metoprolol acid | 上调 | 1.84 | 1.30 | |||||
| 55 | 伊马替尼Imatinib | 上调 | 1.88 | 1.41 | |||||
| 56 | 环吡酮β-D-葡糖苷酸 Ciclopirox beta-D-glucuronide | 上调 | 1.74 | 1.71 | |||||
| 57 | 15-环己基戊醇前列腺素F2α 15-cyclohexylpentanorprostaglandin F2alpha | 上调 | 1.80 | 1.82 | |||||
| 58 | 前列腺素F2α 1,9-内酯 Prostaglandin F2alpha 1,9-lactone | 上调 | 1.83 | 2.01 | |||||
| 59 | 牛磺石胆酸硫酸盐Taurolithocholic acid sulfate | 上调 | 1.65 | 2.08 | |||||
| 60 | 11-脱氧前列腺素E1 11-deoxyprostaglandin E1 | 上调 | 1.80 | 2.19 | |||||
| 61 | N-(1,1叔丁基)-3-[[5-甲基-2-[[4-(4-甲基-1- 哌嗪基)苯基]氨基]-4-嘧啶基]氨基]-苯磺酰胺 N-(1,1-dimethylethyl)-3-[[5-methyl-2-[[4-(4-methyl-1- piperazinyl)phenyl]amino]-4-pyrimidinyl]amino]- benzenesulfonamide | 上调 | 1.82 | 2.21 | |||||
| 62 | 钙霉素Calcimycin | 上调 | 1.85 | 2.21 | |||||
| 63 | 牛磺熊去氧胆酸Tauroursodeoxycholic acid | 上调 | 1.62 | 2.42 | |||||
| 64 | β-D-吡喃葡萄糖苷酸,5-[3-[(2,2,3,3-四甲基 环丙基)羰基]-1氢-吲哚-1-基]戊基 Beta-D-glucopyranosiduronic acid,5-[3-[(2,2,3,3- tetramethylcyclopropyl)carbonyl]-1H-indol-1-yl]pentyl | 上调 | 1.85 | 2.52 | |||||
| 65 | 甘氨胆酸Glycocholate | 上调 | 1.82 | 3.99 | |||||
| 66 | 甘氨鹅脱氧胆酸Glycochenodeoxycholic acid | 上调 | 1.91 | 4.30 | |||||
| 高蛋白质组与中蛋白质组相比High protein group vs. medium protein group | |||||||||
| 1 | 新橙皮糖苷Neohesperidin | 下调 | 2.07 | -2.18 | |||||
| 2 | 脯氨酰-脯氨酸Pro-Pro | 下调 | 2.10 | -1.08 | |||||
| 3 | 磷脂酰肌醇36∶5 Pi 36∶5 | 下调 | 2.13 | -0.97 | |||||
| 4 | N-硬脂酰鞘氨醇(神经酰胺C18) N-stearoylsphingosine (ceramide C18) | 下调 | 1.90 | -0.67 | |||||
| 5 | 升麻素苷H2 Cimicifugoside H2 | 下调 | 1.94 | -0.63 | |||||
| 6 | 缬氨酰丙氨酰赖氨酸Val-Ala-Lys | 上调 | 2.06 | 0.60 | |||||
| 7 | 1-棕榈酰基-2-羟基-sn-甘油-3-磷酸-(1-rac-甘油) 1-palmitoyl-2-hydroxy-sn-glycero-3-phospho-(1-rac-glycerol) | 上调 | 2.05 | 0.67 | |||||
| 8 | β-羟基丁酸Beta-hydroxybutyrate | 上调 | 1.87 | 0.75 | |||||
| 9 | γ-L-谷氨酰-L-谷氨酸 Gamma-L-glutamyl-L-glutamic acid | 上调 | 1.92 | 0.78 | |||||
| 10 | 异戊酰甘氨酸Isovalerylglycine | 上调 | 1.89 | 0.82 | |||||
| 11 | 反式羟基格列美脲Trans-hydroxyglimepiride | 上调 | 2.01 | 0.83 | |||||
| 12 | 前列腺素B2 Prostaglandin B2 | 上调 | 1.88 | 0.90 | |||||
| 13 | 熊胆酸 3alpha,7beta,12alpha-trihydroxy-5beta-cholan-24-oic acid | 上调 | 2.04 | 1.02 | |||||
| 14 | 醋酸,2-[[(2z)-4-[(1r,2r,3r,5r)-5-氯-2-[(3r)-3- 环己基-3-羟丙基]-3-羟基环戊基]-2-丁烯-1-基] 氧基]-1-甲基乙基酯 Acetic acid,2-[[(2z)-4-[(1r,2r,3r,5r)-5-chloro-2-[(3r)-3- cyclohexyl-3-hydroxypropyl]-3-hydroxycyclopentyl]-2- buten-1-yl]oxy]-1-methylethyl ester | 上调 | 2.04 | 1.02 | |||||
| 15 | 3-甲氧基利马前列腺素3-methoxy limaprost | 上调 | 1.94 | 1.14 | |||||
| 16 | α-甲胍戊二酸alpha-guanidinoglutaric acid | 上调 | 2.13 | 1.15 | |||||
| 17 | 苯乙酰甘氨酸Phenylacetylglycine | 上调 | 1.96 | 1.16 | |||||
| 18 | 棉酚Gossypol | 上调 | 2.17 | 1.17 | |||||
| 19 | (全-z)-16,19,22,25,28,31-四碳六烯酸 (all-z)-16,19,22,25,28,31-tetratriacontahexaenoic acid | 上调 | 1.92 | 1.48 | |||||
| 20 | 3-羟基司坦唑醇葡糖苷酸 3-hydroxystanozolol glucuronide | 上调 | 2.22 | 1.54 | |||||
| 21 | (14z,17z,20z,23z,26z,29z)-14,17,20,23,26,29-十二碳六烯酸 (14z,17z,20z,23z,26z,29z)-14,17,20,23,26,29- dotriacontahexaenoic acid | 上调 | 2.03 | 1.61 | |||||
| 22 | 雄甾酮葡糖苷酸Androsterone glucuronide | 上调 | 2.13 | 1.88 | |||||
| 23 | 脱氧胆酸Deoxycholic acid | 上调 | 1.95 | 1.88 | |||||
| 24 | 普伐他汀Pravastatin | 上调 | 2.21 | 1.90 | |||||
| 25 | 胆酸Cholic acid | 上调 | 2.14 | 1.95 | |||||
| 26 | 鹅去氧胆酸24-酰基-β-D-葡糖苷酸 Chenodeoxycholic acid 24-acyl-beta-D-glucuronide | 上调 | 1.85 | 2.25 | |||||
| 27 | 熊果胆酸Ursocholic acid | 上调 | 2.12 | 2.77 | |||||
| 28 | 磷脂酰肌醇34∶0 Pi 34∶0 | 上调 | 2.08 | 3.23 | |||||
| 29 | (r)-4-((3r,5s,7r,8r,9s,10s,12r,13r,14s,17r)-3,7,12- 三羟基-10,13-二甲基十六氢-1氢-环戊并[a]菲-17-基)戊酸 (r)-4-((3r,5s,7r,8r,9s,10s,12r,13r,14s,17r)-3,7,12-trihydroxy- 10,13-dimethylhexadecahydro-1H-cyclopenta[a] phenanthren-17-yl)pentanoic acid | 上调 | 2.08 | 5.30 | |||||
2.3.3 血清差异代谢物代谢通路分析
图4 犊牛血清差异代谢物代谢通路分析A表示低蛋白质组与中蛋白质组相比,B表示低蛋白质组与高蛋白组相比,C表示高蛋白质组与中蛋白质组相比。 Fig.4 Analysis of metabolic pathways of serum differential metabolites of calves A represented low protein group vs. medium protein group, B represented low protein group vs. high protein group, and C represented high protein group vs. medium protein group. |

京公网安备 11010802041926号